Skin temperature of the knee was effectively reduced when using a new continuous cold-flow cryocompression device: a randomised controlled crossover trial
Physiotherapy · 2024
DOI: 10.1016/j.physio.2023.12.001 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Physiotherapy, 2024. Verfasst von James Belsey und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Winchester, Department of Sport, Health & Community, Sparkford Road, Winchester, United Kingdom. Electronic address: KneeResearch@pm.me. Hauptthemen laut MEDLINE: Skin Temperature, Cross-Over Studies, Cryotherapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Winchester, Department of Sport, Health & Community, Sparkford Road, Winchester, United Kingdom. Electronic address: KneeResearch@pm.me.
- University of Winchester, Department of Sport, Health & Community, Sparkford Road, Winchester, United Kingdom.
Zitieren
APA
Belsey, J., Gregory, R., Paine, E., & Faulkner, J. (2024). Skin temperature of the knee was effectively reduced when using a new continuous cold-flow cryocompression device: a randomised controlled crossover trial. Physiotherapy. https://doi.org/10.1016/j.physio.2023.12.001
Vancouver
Belsey J, Gregory R, Paine E, Faulkner J. Skin temperature of the knee was effectively reduced when using a new continuous cold-flow cryocompression device: a randomised controlled crossover trial. Physiotherapy. 2024. doi:10.1016/j.physio.2023.12.001
BibTeX
@article{Belsey2024,
author = {Belsey, James and Gregory, Ryan and Paine, Eloise and Faulkner, James},
title = {Skin temperature of the knee was effectively reduced when using a new continuous cold-flow cryocompression device: a randomised controlled crossover trial},
journal = {Physiotherapy},
year = {2024},
doi = {10.1016/j.physio.2023.12.001}
}
EUVIMED